ASTH · Astrana Health, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-07 | Sobotka Glenn |
Chief Accounting Officer |
Other↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of unvested time-based and performance-based restricted stock that was forfeited in connection with the reporting person's retirement from his positions with the Issuer. Includes 1,300 shares of restricted stock that will vest on an accelerated basis in connection with the reporting person's retirement from his positions with the Issuer, subject to his execution of a release of claims. |
Common Stock
|
11,793 |
| 2026-06-27 | Sim Brandon |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock. Includes 34,207 shares of unvested restricted stock, which will vest in two equal semi-annual installments, beginning September 30, 2026, subject to continuous employment with the Issuer. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 60,347 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; (ii) 109,232 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026; and (iii) 201,056 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026. Includes 1,420 shares acquired under the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
1,093 |
| 2026-06-10 | Dai, Weili |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders. |
Common Stock
|
4,525 |
| 2026-06-10 | Marsh Linda |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders. |
Common Stock
|
4,525 |
| 2026-06-10 | Mazdyasni Matthew |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders. |
Common Stock
|
4,525 |
| 2026-06-10 | Schmidt David |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders. |
Common Stock
|
4,525 |
| 2026-06-10 | Kitayama Mitchell W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. Includes 4,991 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders. |
Common Stock
|
4,991 |
| 2026-06-10 | Chiang John |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders. |
Common Stock
|
4,525 |
| 2026-05-16 | Basho Chandan |
COO and CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on May 16, 2026. Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026. |
Common Stock
|
8,155 |
| 2026-04-14 | Basho Chandan |
COO and CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on April 14, 2026. Includes 30,404 shares of unvested restricted stock, which will vest in two equal annual installments on May 16, 2026 and 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026. |
Common Stock
|
3,870 |
| 2026-04-06 | Sim Kenneth T. |
Director, Executive Chairman |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer and/or its affiliates on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 6, 2026. Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer and/or its affiliates): (i) 78,334 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 66,667 shares, which will vest in two equal annual installments beginning on April 1, 2027. Also includes 100,000 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026 (subject to continuous employment with the Issuer and/or its affiliates). |
Common Stock
|
100,000 |
| 2026-04-06 | Sim Brandon |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 6, 2026. Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 29,919 shares, which will vest on June 27, 2026; and (ii) 34,207 shares, which will vest in two equal semi-annual installments, beginning September 30, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 60,347 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; (ii) 109,232 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026; and (iii) 201,056 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026. Includes 1,420 shares acquired under the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
201,056 |
| 2026-04-06 | Lam Thomas S. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer and/or its affiliates on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 6, 2026. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer and/or its affiliates): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 13,334 shares, which will vest in two equal annual installments beginning on April 1, 2027. Also includes 41,667 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026 (subject to continuous employment with the Issuer and/or its affiliates). |
Common Stock
|
41,667 |
| 2026-04-02 | Basho Chandan |
COO and CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on April 2, 2026. Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026. |
Common Stock
|
2,092 |
| 2026-04-01 | Kumar Dinesh M. |
Chief Med & Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock and restricted stock units that vested on April 1, 2026. Includes 28,378 shares of restricted stock, which will vest on January 23, 2027 (subject to continuous employment with the Issuer). Also includes 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026 (subject to continuous employment with the Issuer). Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
57,980 |
| 2026-04-01 | Kumar Dinesh M. |
Chief Med & Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Shares delivered to the reporting person pursuant to the vesting of performance-based restricted stock units that vested upon achievement of performance goals for the applicable performance period. The reporting person reported an acquisition of 67,238 performance-based restricted stock units on a Form 4 filed November 12, 2024, which represented the number of shares that would be delivered if target performance was achieved during the performance period. Actual performance exceeded the target performance for the performance period, which resulted in an additional grant of 35,300 shares. |
Common Stock
|
35,300 |
| 2026-03-26 | Sobotka Glenn |
Chief Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on March 26, 2026. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 4,824 shares, which will vest in three equal annual installments beginning on March 26, 2027; and (ii) 8,269 shares, which will vest subject to the achievement of certain performance goals. |
Common Stock
|
662 |
| 2026-03-05 | Basho Chandan |
COO and CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on March 5, 2026. Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 19,504 restricted stock units, which will vest in five equal semi-annual installments beginning on April 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026. |
Common Stock
|
1,240 |
| 2026-03-05 | Lam Thomas S. |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with shares of restricted stock that vested on March 5, 2026. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals. |
Common Stock
|
9,266 |
| 2026-03-05 | Kumar Dinesh M. |
Chief Med & Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on March 5, 2026. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 28,378 shares, which will vest on January 23, 2027; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026. Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
1,697 |
| 2026-02-02 | Sim Brandon |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 29,919 shares, which will vest on June 27, 2026; and (ii) 51,309 shares, which will vest in three equal semi-annual installments, beginning March 31, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 75,433 restricted stock units, which will vest in five equal semi-annual installments beginning on April 2, 2026; and (ii) 127,437 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026. Includes 1,420 shares acquired under the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
21,334 |
| 2026-02-02 | Sim Brandon |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options were fully vested and exercisable. |
Stock Option (right to buy)
|
21,334 |
| 2026-01-23 | Kumar Dinesh M. |
Chief Med & Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on January 23, 2026. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 28,378 shares, which will vest on January 23, 2027; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026. Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
10,759 |
| 2026-01-13 | Schmidt David |
Director |
Convert↑
|
Common Stock
|
20,000 |
| 2026-01-13 | Schmidt David |
Director |
Convert↓
Filing footnotes — Stock Option (right to Buy) (Direct)
These stock options were fully vested and exercisable. |
Stock Option (right to Buy)
|
20,000 |
| 2026-01-13 | Schmidt David |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. |
Common Stock
|
4,269 |
| 2026-01-01 | Kumar Dinesh M. |
Chief Med & Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on January 1, 2026. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 56,754 shares, which will vest in two equal annual installments beginning on January 23, 2026; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026. Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
5,102 |
| 2025-12-08 | Lam Thomas S. |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options were fully vested and exercisable. |
Stock Option (right to buy)
|
29,502 |
| 2025-12-08 | Lam Thomas S. |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 77,500 shares, which will vest in three equal annual installments beginning on March 5, 2026; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals. |
Common Stock
|
25,866 |
| 2025-12-08 | Lam Thomas S. |
Director |
Convert↑
|
Common Stock
|
29,502 |
| 2025-11-10 | Mazdyasni Matthew |
Director |
Convert↓
Filing footnotes — Stock Option (right to Buy) (Direct)
These stock options were fully vested and exercisable. |
Stock Option (right to Buy)
|
20,000 |
| 2025-11-10 | Sim Kenneth T. |
Director, Executive Chairman |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 117,501 shares, which will vest in three equal annual installments beginning on March 5, 2026; and (ii) 133,333 shares, which will vest upon achievement of certain pre-established performance goals. |
Common Stock
|
29,502 |
| 2025-11-10 | Sim Kenneth T. |
Director, Executive Chairman |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options were fully vested and exercisable. |
Stock Option (right to buy)
|
29,502 |
| 2025-11-10 | Mazdyasni Matthew |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. |
Common Stock
|
20,000 |
| 2025-11-07 | Kitayama Mitchell W |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. |
Common Stock
|
12,000 |
| 2025-11-07 | Kitayama Mitchell W |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options were fully vested and exercisable. |
Stock Option (right to buy)
|
12,000 |
| 2025-11-03 | Marsh Linda |
Director |
Convert↓
Filing footnotes — Stock Option (right to Buy) (Direct)
These stock options were fully vested and exercisable. |
Stock Option (right to Buy)
|
20,000 |
| 2025-11-03 | Marsh Linda |
Director |
Convert↑
|
Common Stock
|
20,000 |
| 2025-11-03 | Marsh Linda |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. |
Common Stock
|
11,033 |
| 2025-10-02 | Basho Chandan |
COO and CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 2, 2025. Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 19,504 restricted stock units, which will vest in five equal semi-annual installments beginning on April 2, 2026; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026. |
Common Stock
|
1,979 |
| 2025-09-15 | Kitayama Mitchell W |
Director |
Other↓
Filing footnotes — Common Stock (Direct)
These shares were repurchased by the Issuer. |
Common Stock
|
8,000 |
| 2025-09-15 | Kitayama Mitchell W |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options were fully vested and exercisable. |
Stock Option (right to buy)
|
8,000 |
| 2025-09-15 | Kitayama Mitchell W |
Director |
Other↓
Filing footnotes — Common Stock (Direct)
These shares were repurchased by the Issuer. Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. |
Common Stock
|
5,214 |
| 2025-09-15 | Kitayama Mitchell W |
Director |
Convert↑
|
Common Stock
|
8,000 |
| 2025-09-05 | Kumar Dinesh M. |
Chief Med & Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2025. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 56,754 shares, which will vest in two equal annual installments beginning on January 23, 2026; (ii) 13,464 shares, which will vest on January 1, 2026; and (iii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026. Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
1,694 |
| 2025-09-05 | Basho Chandan |
COO and CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2025. Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 23,404 restricted stock units, which will vest in six equal semi-annual installments beginning on October 2, 2025; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026. |
Common Stock
|
1,694 |
| 2025-09-02 | Schmidt David |
Director |
Convert↓
Filing footnotes — Stock Option (right to Buy) (Direct)
These stock options were fully vested and exercisable. |
Stock Option (right to Buy)
|
20,000 |
| 2025-09-02 | Schmidt David |
Director |
Convert↑
|
Common Stock
|
20,000 |
| 2025-09-02 | Schmidt David |
Director |
Other↓
Filing footnotes — Common Stock (Direct)
These shares were repurchased by the Issuer. Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. |
Common Stock
|
20,000 |
| 2025-08-13 | Chiang John |
Director |
Convert↑
|
Common Stock
|
20,000 |